Canton Strategic Holdings, Inc. Common Stock CNTN Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|
| Operating Income by Business | ||||
| Digital Asset Treasury | -$37.3M— | -$2.77M— | —— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||
| Digital Asset Treasury | -$68.48M— | -$24.75M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Canton Strategic Holdings, Inc. Common Stock break its business down?
- Canton Strategic Holdings, Inc. Common Stock (CNTN) reports operating income by business across 2 parts — Clinical Stage Bio Technology and Digital Asset Treasury. Each is extracted from the segment footnotes and tracked over time.
- Where does Canton Strategic Holdings, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canton Strategic Holdings, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.